Skip to main content

Table 2 Characteristics of Included Guidelines

From: The Systematic Guideline Review: Method, rationale, and test on chronic heart failure

Source

Organisation, Country of Origin

Covered Scope†

No. of Authors

Literature Search: Period/Databases

No. of References

ACC/AHA 2001 [50]

American College of Cardiology/American Heart Association, U.S.A.

D, T

14

Period not specified MEDLINE, EMBASE

573

AKDAE 2001 [45]

Drug Commission of the German Medical Association, Germany

P

Not specified

No systematic search

216

CCS 2001 [56], 2002/3 [55]

Canadian Cardiovascular Society, Canada

D, T

Not specified

Period not specified MEDLINE

2001: 79; 2002/3: 42

DGK 2001 [46]

German Cardiac Society, Germany

T

2

1990–2000; Databases: not specified

213

DieM 2003/2004 [47]

Institute for Evidence-Based Medicine, Germany

T

3

Period not specified (Last 03/2003); MEDLINE, Cochrane Library, „Best Evidence"

42

Duodecim 2004 [60]

The Finnish Medical Society Duodecim, Finland

D, T

Not specified

Period not specified (Last 03/2004); DARE, „Best Evidence"

Ca. 50††

DVA & VHA 2002 [51]

Department of Veterans Affairs & Veterans Health Administration, U.S.A.

P

14*

Update search 01/2001 to 11/2002; MEDLINE

197

ESC 2002/2001 [62]

European Society of Cardiology, (Europe)

D, T

18

Not specified

196

ICSI 2003 [52]

Institute for Clinical System Improvement, U.S.A.

D, T

11

Not specified

Ca. 50

LLGH 2003 [48]

'Leitliniengruppe' (Group of Family Physicians in Hesse), Germany

(D), T

2

Period not specified MEDLINE

72

NHF/Austr & SANZ 2002 [58]

National Heart Foundation of Australia and Cardiac Society of Australia & New Zealand

D, T

33

Not specified

143

NHF/NZ 2001 [59]

The National Heart Foundation of New Zealand

D, T

19

Period not specified (Last 04/2000); MEDLINE

44

NICE 2003 [61]

The National Collaborating Centre for Chronic Conditions/National Institute for Clinical Excellence, United Kingdom

D, T

15**

Start of the Database until 09/2002; MEDLINE, EMBASE, CINAHL, PsycINFO, AMED, Cochrane Library, EconLit

347‡

OPOT 2000 [57]

Ontario Program for Optimal Therapeutics, Canada

P

Not specified

Not specified

24

UM 2001 [53, 54]

University of Michigan, U.S.A.

D, T

6

1994 – 02/1998, + hand searches until 2001; MEDLINE

50

UWH 2001 [49]

Faculty of Medicine, University Witten/Herdecke, Germany

D, T

5 + 2‡‡

Not specified

157

  1. †Limitation on recommendations with evidence levels and/or grading; ††Ascertainment possibly incomplete because of document structure (internet-based version with links to other documents); *Supported by 13 members of The Medical Advisory; **Support from 14 members of the Guideline Reference Group; ‡Additional citations in evidence tables not counted; ‡‡Additional advisors from specialized care; Abbreviations:D – diagnostics, (D) – diagnostics partly, T – therapy, P – pharmacotherapy only